BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Q: What does CUSIP 09075V102 represent in this 13F holders report?

CUSIP 09075V102 is the security identifier for BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) used to aggregate holder disclosures.

Q: How many institutions held BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in Q3 2020?

144 institutional investors reported BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: 09075V102

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Shares outstanding: 239,647,920
Total 13F shares: 24,274,421
Share change: -2,353,527
Total reported value: $1,679,824,791
Put/Call ratio: 203%
Price per share: $69.23
Number of holders: 144
Value change: -$160,429,955
Number of buys: 103
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 09075V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.3%	10,210,814	$681,470,000	—	30 Jun 2020	13F
Redmile Group, LLC	13F	Company	1.3%	3,069,164	$204,836,000	—	30 Jun 2020	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.2%	2,772,792	$185,056,000	—	30 Jun 2020	13F
Artal Group S.A.	13F	Company	0.83%	2,000,000	$133,480,000	—	30 Jun 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.65%	1,551,278	$103,532,000	—	30 Jun 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.49%	1,169,133	$78,028,000	—	30 Jun 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.25%	597,212	$39,858,000	—	30 Jun 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.22%	525,075	$35,043,000	—	30 Jun 2020	13F
HealthCor Management, L.P.	13F	Company	0.21%	503,920	$33,632,000	—	30 Jun 2020	13F
S.c.a. Candriam	13F	Individual	0.17%	410,313	$27,386,000	—	30 Jun 2020	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.15%	367,788	$24,546,000	—	30 Jun 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.15%	355,161	$23,703,000	—	30 Jun 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.12%	297,000	$19,822,000	—	30 Jun 2020	13F
Logos Global Management LP	13F	Company	0.12%	295,000	$19,688,000	—	30 Jun 2020	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.09%	215,785	$14,401,000	—	30 Jun 2020	13F
Duquesne Family Office LLC	13F	Company	0.09%	204,450	$13,645,000	—	30 Jun 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.08%	202,206	$13,495,228	—	30 Jun 2020	13F
Cormorant Asset Management, LP	13F	Company	0.07%	175,000	$11,680,000	—	30 Jun 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	168,098	$11,219,000	—	30 Jun 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	148,049	$9,881,000	—	30 Jun 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.06%	140,068	$9,348,000	—	30 Jun 2020	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.04%	103,800	$6,868,000	—	30 Jun 2020	13F
Invesco Ltd.	13F	Company	0.04%	98,113	$6,548,000	—	30 Jun 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	54,600	$3,644,000	—	30 Jun 2020	13F
UBS Group AG	13F	Company	0.02%	52,838	$3,527,000	—	30 Jun 2020	13F
Bellevue Group AG	13F	Company	0.02%	50,000	$3,337,000	—	30 Jun 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	47,563	$3,186,000	—	30 Jun 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.02%	46,413	$3,098,000	—	30 Jun 2020	13F
Allianz Asset Management GmbH	13F	Company	0.02%	43,345	$2,892,000	—	30 Jun 2020	13F
SEI INVESTMENTS CO	13F	Company	0.02%	41,119	$2,744,000	—	30 Jun 2020	13F
Sivik Global Healthcare LLC	13F	Company	0.02%	40,000	$2,670,000	—	30 Jun 2020	13F
Graticule Asia Macro Advisors LLC	13F	Company	0.02%	38,650	$2,580,000	—	30 Jun 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.02%	38,626	$2,578,000	—	30 Jun 2020	13F
SG Americas Securities, LLC	13F	Company	0.01%	35,681	$2,381,000	—	30 Jun 2020	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.01%	31,869	$2,127,000	—	30 Jun 2020	13F
Vident Investment Advisory, LLC	13F	Company	0.01%	30,787	$2,055,000	—	30 Jun 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	24,148	$1,611,000	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0.01%	23,205	$1,548,000	—	30 Jun 2020	13F
Zurcher Kantonalbank (Zurich Cantonalbank)	13F	Company	0.01%	22,415	$1,496,000	—	30 Jun 2020	13F
Laurion Capital Management LP	13F	Company	0.01%	20,169	$1,346,000	—	30 Jun 2020	13F
SevenBridge Financial Group, LLC	13F	Company	0.01%	18,627	$1,243,000	—	30 Jun 2020	13F
AVIVA PLC	13F	Company	0.01%	18,400	$1,233,000	—	30 Jun 2020	13F
COMERICA BANK	13F	Company	0%	11,739	$1,223,000	—	30 Jun 2020	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.01%	17,900	$1,195,000	—	30 Jun 2020	13F
Marshall Wace North America L.P.	13F	Company	0.01%	17,428	$1,163,000	—	30 Jun 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	17,008	$1,135,000	—	30 Jun 2020	13F
Caption Management, LLC	13F	Company	0.01%	16,800	$1,117,000	—	30 Jun 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	15,900	$1,061,000	—	30 Jun 2020	13F
CREDIT SUISSE AG/	13F	Company	0.01%	15,355	$1,025,000	—	30 Jun 2020	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.01%	14,505	$954,000	—	30 Jun 2020	13F

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q3 2020

As of 30 Sep 2020, BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,274,421 shares. The largest 10 holders included FMR LLC, PRIMECAP MANAGEMENT CO/CA/, Artisan Partners Limited Partnership, Artal Group S.A., Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, AMERIPRISE FINANCIAL INC, Invesco Ltd., and WELLINGTON MANAGEMENT GROUP LLP. This page lists 144 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

108

Q3 2020 holders

144

Holder diff

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.